Evolution Wealth Advisors, LLC Bei Gene, Ltd. Transaction History

Evolution Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$121.84 - $173.19 $10,478 - $14,894	-86 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$115.78 - $208.34 $9,146 - $16,458	79 Added 1128.57%	86 $14,000
Q3 2019 Nov 12, 2019	SELL	$120.61 - $148.29 $8,925 - $10,973	-74 Reduced 91.36%	7 $1,000
Q2 2019 Jul 12, 2019	BUY	$113.99 - $146.86 $9,233 - $11,895	81 New	81 $10,000

253

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.7B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.